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Abstract
Objective—Data describing the prevalence, characteristics and management of coronary chronic 
total occlusions (CTOs) in patients undergoing coronary CT angiography (CCTA) have not been 
reported. The purpose of this study was to determine the prevalence, characteristics and treatment 
strategies of CTO identified by CCTA.
Methods—We identified 23 745 patients who underwent CCTA for suspected coronary artery 
disease (CAD) from the prospective international CCTA registry. Baseline clinical data were 
collected, and allocation to early coronary revascularisation performed within 90 days of CCTA 
was determined. Multivariable hierarchical mixed-effects logistic regression reporting OR with 
95% CI was performed.
Results—The prevalence of CTO was 1.4% (342/23 745) in all patients and 6.2% in patients 
with obstructive CAD (≥50% stenosis). The presence of CTO was independently associated with 
male sex (OR 3.12, 95% CI 2.39 to 4.08, p<0.001), smoking (OR 2.02, 95% CI 1.55 to 2.64, 
p<0.001), diabetes (OR 1.60, 95% CI 1.22 to 2.11, p=0.001), typical angina (OR 1.51, 95% CI 
1.12 to 2.06, p=0.008), hypertension (OR 1.47, 95% CI 1.14 to 1.88, p=0.003), family history of 
CAD (OR 1.30, 95% CI 1.01 to 1.67, p=0.04) and age (OR 1.06, 95% CI 1.05 to 1.07, p<0.001). 
Most patients with CTO (61%) were treated medically, while 39% underwent coronary 
revascularisation. In patients with severe CAD (≥70% stenosis), CTO independently predicted 
revascularisation by coronary artery bypass grafting (OR 3.41, 95% CI 2.06 to 5.66, p<0.001), but 
not by percutaneous coronary intervention (p=0.83).
Conclusions—CTOs are not uncommon in a contemporary CCTA population, and are 
associated with age, gender, angina status and CAD risk factors. Most individuals with CTO 
undergoing CCTA are managed medically with higher rates of surgical revascularisation in 
patients with versus without CTO.
Trial registration number—ClinicalTrials.gov identifier NCT01443637.
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INTRODUCTION
Coronary CT angiography (CCTA) is a useful non-invasive tool that demonstrates high 
performance for diagnosis and prognosis of coronary artery disease (CAD).1–3 Further, 
CCTA demonstrates precision for assessing the anatomical and morphological features of 
occluded coronary arteries, and has been successfully employed in the planning of chronic 
total occlusion (CTO) revascularisation.4–6
While the prevalence of CTO has been defined for individuals undergoing invasive coronary 
angiography,7–10 data describing the prevalence and clinical characteristics of occluded 
coronary arteries among stable patients referred for non-invasive testing have not been 
reported to date. To this end, whether CTO influences the current management of CAD after 
non-invasive imaging remains unclear. The purpose of this investigation was to determine 
the prevalence of CTO in a consecutive multinational CCTA population and to provide 
detailed clinical and tomographic characteristics associated with CTO. The influence of 
CTO at the time of CCTA on treatment strategies was additionally examined.
METHODS
Study population
The CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An 
InteRnational Multicenter) registry is an international multicentre observational registry 
collecting clinical, procedural and follow-up data of patients who underwent CCTA between 
2005 and 2010 at 17 centres in 7 countries (USA, Canada, Germany, Switzerland, Italy, 
Austria and South Korea). A detailed description of the study design has been published 
elsewhere.11 For the purpose of the present analysis, patients who underwent CCTA for 
suspected, but without prior known CAD, were included. The exclusion criterion of known 
CAD was defined as previous myocardial infarction and/or coronary revascularisation. 
Ethical approval was obtained from each of the study centres’ institutional review board 
committees, and written informed consent was provided by the study participants.
The CONFIRM registry employs a standardised data collection method at all study sites to 
gather information regarding baseline cardiovascular risk factors, symptoms and medication 
before CCTA, as well as detailed angiographic results and clinical outcomes.12 Pretest 
probability of CAD was defined using the Diamond–Forrester score,13 and symptom 
presentation was classified into the following categories: typical chest pain, atypical chest 
pain and non-cardiac pain.14 Coronary artery calcium was quantified according to the 
method of Agatston. Details of this approach have been described elsewhere.15
Image acquisition and analysis
CCTA data acquisition was performed using at minimum a 64-slice CT scanner with the 
imaging protocol adhering to the Society of Cardiovascular Computed Tomography 
guidelines on appropriateness and performance of CCTA.16 Dose-reduction strategies, 
including ECG-gated tube current modulation, reduced tube voltage and prospective axial 
triggering, were used whenever possible, with estimated radiation doses for CCTA ranging 
from 3 to 18 mSv.
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Reconstructed data were evaluated in a uniform fashion across all study sites by level III-
qualified readers using all necessary postprocessing techniques to determine the presence of 
CAD. Coronary segments were scored visually for the presence and composition of 
coronary plaque and degree of luminal stenosis with a 16-segment American Heart 
Association coronary artery model.17 Plaque severity was graded on a per-segment, per-
vessel and per-patient level. Plaque composition in each coronary segment was classified as 
non-calcified, partially calcified or calcified as defined elsewhere.18 Coronary 
atherosclerotic lesions were graded as normal (no atherosclerosis), mild (1%–49% stenosis), 
moderate (50%–69% stenosis), severe (70%–99%) or totally occluded (100%) in epicardial 
coronary arteries of ≥2 mm in diameter. Coronary lesions with ≥50% luminal stenosis 
severity were defined as obstructive.
Per-vessel obstructive CAD was defined by ≥50% stenosis (including CTO) in 0, 1, 2 or 3 
coronary artery vessels. For the purpose of classification for per-vessel analyses, we 
included four arterial territories: left main artery, left anterior descending artery, left 
circumflex artery and right coronary artery. The diagonal branches and obtuse marginal 
branches were considered as part of the left anterior descending artery and left circumflex 
artery system, respectively, whereas the posterolateral branches and posterior descending 
artery were considered as part of the right coronary artery or left circumflex artery system, 
depending on the coronary artery dominance.19 Additionally, the proximal segments were 
defined as follows: left main, proximal and mid left anterior descending artery; proximal left 
circumflex artery and first obtuse marginal branch; and proximal and mid right coronary 
artery.18 Per-patient obstructive CAD was defined by the maximal stenosis in ≥1 coronary 
vessel at the 50% stenosis threshold. Given that severe CAD (≥70% stenosis) is mainly 
associated with coronary ischaemia, and the need for coronary revascularisation, 
subanalyses were performed for patients with at least one coronary stenosis at the ≥70% 
luminal narrowing threshold to investigate CTO treatment allocation.
CTO was defined as complete interruption of the contrast-enhanced lumen of the coronary 
artery with recurrence of luminal opacification distal to the occlusion site as assessed by 
multiplanar reconstructions by CCTA.2021 The prevalence of CTO was determined using 
two denominators: (1) all patients undergoing CCTA and (2) patients with obstructive CAD.
Study outcomes
The primary endpoint was prevalent CTO as determined by CCTA. In patients with follow-
up for early coronary revascularisation, a secondary endpoint of target vessel coronary 
revascularisation performed within 90 days after the time of CCTA was assessed.22
Statistical methods
Categorical variables were presented as counts with proportions and were assessed using 
Pearson’s χ2 or Fisher’s exact test for cell counts <6. Continuous variables were presented as 
mean ±SD when normally distributed or median with IQR when non-normally distributed, 
and analysed using Student’s unpaired t test or Mann–Whitney U test, as appropriate. The 
variables with significant missing values (>15%) were noted. Pairwise comparisons of 
plaque morphology were obtained using one-sample t tests, and were adjusted to account for 
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multiple comparisons (ie, three pairwise comparisons) using the Bonferroni method. Clinical 
variables known or suspected to be associated with the presence of CTO or post-test 
revascularisation strategies were assessed using univariable and multivariable hierarchical 
mixed-effects logistic regression modelling, with hospital sites considered random effects, 
reporting ORs with 95% CIs. For this reason, we made the following assumptions: random 
effects follow a Gaussian distribution, the conditional distribution of the response is 
assumed to be Bernoulli with probability of success determined by cumulative distribution 
function, and the log-likelihood is approximated by adaptive Gaussian quadrature.23 
Statistical significance was accepted for two-tailed p values <0.05. All calculations were 
performed using STATA V.12.1 (Stata, College Station, Texas, USA).
RESULTS
Prevalence of CTO
Of a total of 27 125 screened adult patients, we excluded patients with known CAD 
(n=2350), congenital heart disease (n=111) and patients for whom clinical data regarding 
age, gender or CAD severity were lacking (n=919), resulting in a fnal study sample of 23 
745 individuals. The prevalence of CTO for the entire study cohort (definition 1) was 1.4% 
(342/23 745). In patients with obstructive CAD (≥50% stenosis threshold), the prevalence of 
CTO was 6.2% (342/5559).
Clinical and angiographic characteristics of CTO
Demographic characteristics according to the presence or absence of CTO by CCTA are 
reported in table 1. The majority of individuals with CTO presented with a low-to-
intermediate probability of obstructive CAD. Approximately two-thirds of the study sample 
presenting with CTO were symptomatic, with the most common presentation of atypical 
angina, followed by typical angina and non-cardiac chest pain. Mean age was higher for 
patients with CTO, with a higher prevalence of male sex and CAD risk factors with the 
exception of family history of premature CAD. In patients with LVEF data availability (33% 
of the study cohort), the majority of individuals with CTO exhibited normal LVEF, although 
LVEF was significantly lower among patients with CTO.
Prevalence of significant CAD among patients with CTO was equally distributed into one-
vessel (33%), two-vessel (31.9%) and three-vessel or left-main CAD (35.1%). In total, 380 
vessels (172 right coronary arteries, 114 left anterior descending arteries, 94 left circumflex 
arteries) were totally occluded, with the majority of individuals with single-vessel CTO 
(89.2%), followed by patients with two-vessel CTO (10.5%) and three-vessel CTO (0.3%), 
respectively. The most common CTO was the right coronary artery identified in 50.3% of 
patients with CTO, with 33.3% and 27.4% of individuals manifesting left anterior 
descending and left circumflex artery CTO, respectively. The location of CTO was in the 
proximal portion of the coronary arteries in the majority (57.1%) of cases (distribution of 
proximal occlusion per vessel: right coronary artery 63%; left anterior descending artery 
54.9%; left circumflex artery 45.5%), with most CTOs being calcified or partially calcified 
(table 2).
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Predictors of CTO
Multivariable mixed-effects logistic regression analyses revealed CTO to be associated with 
male sex, current smoking status, diabetes, typical angina, hypertension, family history of 
premature CAD and age. Conversely, the odds of prevalent CTO were reduced on the 
background of normal LVEF (table 3).
Early treatment strategies
Follow-up for early coronary revascularisation was available in 15 163 of the study sample, 
of which CTO was prevalent in 281 (1.9%) patients. Most patients with CTO (61%) were 
treated by medical therapy, while approximately one-third (39%) underwent early coronary 
revascularisation by surgical or percutaneous methods. In the subgroup of 1372 patients 
presenting with at least one severe coronary stenosis (≥70%), those with CTO were referred 
more often to coronary artery bypass grafting in lieu of lower rates of percutaneous coronary 
intervention as compared with patients without CTO (figure 1). Early referral patterns 
stratified by the presence of coronary vessel disease showed that surgical revascularisation 
was most often attempted in the subgroup of patients with CTO with three-vessel or left-
main CAD, whereas percutaneous coronary revascularisation was most often chosen in 
subjects without CTO, but with one-vessel disease (table 4). By multivariable mixed-effects 
logistic regression analysis, early revascularisation by percutaneous coronary intervention 
among patients with ≥1 severe coronary stenosis (≥70%) was related to typical angina (OR 
1.94, 95% CI 1.36 to 2.76, p<0.001), atypical angina (OR 1.66, 95% CI 1.21 to 2.29, 
p=0.002), age (OR 0.98, 95% CI 0.97 to 0.99, p=0.001) and hypertension (OR 0.76, 95% CI 
0.58 to 1.00, p=0.048), and was not associated with the presence of CTO (OR 0.96, 95% CI 
0.68 to 1.35, p=0.83). Conversely, the presence of CTO (OR 3.41, 95% CI 2.06 to 5.66, 
p<0.001) was the strongest independent predictor for early revascularisation by coronary 
artery bypass grafting among patients with ≥1 severe coronary stenosis (≥70%), followed by 
multivessel or left main obstructive CAD (OR 3.09, 95% CI 1.87 to 5.12, p<0.001), atypical 
angina (OR 1.71, 95% CI 1.01 to 2.92, p=0.047), current smoking status (OR 1.69, 95% CI 
1.06 to 2.68, p=0.027) and hyperlipidaemia (OR 1.68, 95% CI 1.03 to 2.74, p=0.036). 
Patients with CTO referred to percutaneous coronary intervention (n=68) versus coronary 
artery bypass grafting (n=42) differed for the extent of obstructive CAD, LV systolic 
function and hyperlipidaemia (table 5).
DISCUSSION
In a prospective contemporary multinational registry of consecutive individuals undergoing 
CCTA, this present study set out to determine the prevalence, characteristics and clinical 
management of CTO among patients without prior known CAD. We observed the 
prevalence of CTO to be low, but significantly increased in the presence of obstructive 
CAD. Presence of CTO by CCTA was associated with male sex, current smoking, diabetes, 
hypertension, family history of CAD, age and angina presentation. The majority of patients 
with CTO were symptomatic and yet demonstrated well-preserved LV systolic function, 
with referral to coronary revascularisation in approximately one-third of patients. Notably, 
the findings from this study may be considered widely generalisable given the high number 
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of enrolled subjects and inclusion of multiple clinical sites in North America, Europe and 
Asia.
To date, the prevalence of CTO has been assessed only in higher risk patients undergoing 
invasive coronary angiography.7–10 Prior studies have demonstrated frequencies of CTO 
ranging from 35% to 52% among patients with obstructive CAD.79 More recently, in a 
prospective three-centre coronary angiography registry,10 CTOs were discovered in 18.4% 
of patients with obstructive CAD. The disparity in the frequency of CTO between the 
current findings and prior angiographic reports is unsurprising given the generally lower risk 
presentation of CCTA population. Interestingly, the majority of individuals with CTO in our 
cohort presented with a low-to-intermediate rather than high probability of obstructive CAD. 
This study offers information incremental to that of invasive angiographic observations on 
CTO occurrence, and extends the understanding of CTO prevalence in patients with a lower 
likelihood presentation undergoing non-invasive angiography.
To date, few studies have assessed the angiographic characteristics of CTO in an unselected 
patient population. From data developed through the 1997–1999 National Heart, Lung and 
Blood Institute Dynamic Registry, CTOs were observed to be most prevalent in the right 
coronary artery and least common in the left circumflex artery.24 Similar results were 
encountered in the prospective study of Fefer et al10 who identified the right coronary artery 
as the site of CTO in the majority of cases. These findings are in accordance with our 
present data confirming the highest prevalence of CTO within the right coronary artery 
region. Interestingly, we observed an equal distribution of one-vessel, two-vessel and three-
vessel or left main obstructive disease among patients with CTO. Further, the majority of 
CTO lesions showed calcified or partially calcified plaque morphologies. Provided that the 
extent and severity of calcification increase with occlusion duration,25 this observation may 
be interpreted as indirect evidence for the predominance of older CTO in our cohort. These 
findings may offer clues as to the pathogenesis of CTO, and large-scale longitudinal studies 
assessing plaque composition and other atherosclerotic plaque features among individuals at 
risk of CTO development now appear warranted.
In a single-centre registry of 8004 patients undergoing invasive coronary angiography, 
Christofferson et al9 linked peripheral vascular disease, smoking and hypertension to the 
presence of CTO. Other angiographic studies either found increasing age or prior 
myocardial infarction to be positively associated with CTO.2426 In lieu of these findings, the 
current investigation may be considered the first to report on clinical predictors and 
symptomatic status of unselected patients with CTO undergoing CCTA. Interestingly, while 
expectedly advancing age, male sex, current smoking, diabetes, hypertension, family history 
of premature CAD and typical angina conferred higher risk for CTO, we noted a strong 
relationship between increasing LVEF and attenuation of risk of CTO. The present findings 
are in line with prior pioneer studies emphasising the increasing prevalence, severity and 
extent of CAD in patients with a higher burden of main cardiovascular risk factors.1327 Yet, 
the present study findings examining individuals with lower pretest probability of 
obstructive CAD observed a non-negligible rate of CTOs, and emphasise the importance of 
integration of CAD risk factors and symptom presentation to forecast the presence of CTO. 
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To this end, the present data underline the need to develop a future predictive model for 
identifying the presence of CTO in lower risk populations, including asymptomatic subjects.
There are scant data about the practicing trends regarding referral patterns and management 
for a CTO population. Mostly, patients undergoing coronary revascularisation for CTO have 
stable or progressive angina with preserved LV function and/or documented ischaemia.2829 
In the present study, merely 39.1% of subjects with CTO were referred for early coronary 
revascularisation despite most CTO individuals presenting with symptoms consistent with 
angina and normal LV function. Whether these individuals will derive clinical benefit from 
CTO revascularisation remains to be determined. By relevance, the presence of CTO was 
related to significantly higher surgical revascularisation rates and lower percutaneous 
revascularisation rates when compared with individuals presenting with severe CAD, but 
without CTO. Further, in the current study, CTO was the strongest predictor for coronary 
artery bypass grafting, but was unrelated to the use of percutaneous coronary intervention. 
This finding contrasts with a prior registry analysis employing invasive catheterisation in 
which CTO was the strongest predictor against percutaneous coronary intervention with no 
significant impact on the referral patterns for coronary artery bypass grafting.9 Instead, the 
rates of coronary revascularisation by either percutaneous coronary intervention or coronary 
artery bypass grafting observed in the current study corresponded well with findings of a 
more recent prospective angiography registry.10 The disparity between our and prior 
angiographic studies with regard to early management of patients with CTO may be 
temporally influenced, or may represent a function of differing pretest probability 
presentations as well as wide variability between percutaneous coronary intervention centres 
in successful revascularisation of CTO. Not surprisingly, patients referred for coronary 
artery bypass grafting presented with more extensive CAD, including left main involvement, 
and worse LV systolic function than patients referred for percutaneous coronary 
intervention. This finding may, in part, explain the stronger association between the 
presence of CTO and early revascularisation by coronary artery bypass grafting than 
percutaneous coronary intervention.
This study is not without limitations. This was an observational multicentre registry with 
variable pretest probability of CAD for individuals at different sites. Yet, the results of this 
study regarding the prevalence and significance of CTO among patients referred for CCTA 
were based on the largest currently available pooled patient cohort, and may serve to 
generate hypotheses for the design of future trials. The adopted definition of CTO did not 
account for the estimated time of occlusion prior to non-invasive angiographic interrogation, 
which may have influenced the perceived rate of revascularisation of occluded vessels in our 
cohort. Based on a previous histopathology study,25 however, the predominance of calcified 
and partially calcified CTO morphology are in accordance with observations in the present 
study, and may offer clues as to the approach of CTOs once identified by CCTA. CTO was 
defined by CCTA and not coronary angiography; therefore, the possibility of false-positive 
and false-negative CCTA findings may exist. Finally, the reported referral patterns of 
patients with CTO to percutaneous coronary intervention or coronary artery bypass grafting 
were not governed by standard criteria, but rather clinician discretion. Thus, the possibility 
of selection bias that is present in all observational studies cannot be discounted.
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CONCLUSIONS
The present study represents the first data to determine the prevalence, characteristics and 
treatment strategies of CTO among patients undergoing non-invasive angiography for 
suspected CAD in a contemporary clinical setting; and demonstrates a low, but non-
negligible, rate of CTO that is more prevalent in individuals with obstructive CAD and low-
to-intermediate probability of obstructive CAD. The presence of CCTA-identified CTO was 
strongly associated with age, gender, angina status and CAD risk factors. Despite the 
presence of symptoms and preserved LVEF, the majority of patients with CTO were 
managed medically, with CTO a stronger predictor of surgical rather than percutaneous 
revascularisation.
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Key messages
What is already known on this subject?
While coronary CT angiography (CCTA) has been successfully employed in the planning 
of chronic total occlusion (CTO) revascularisation, data describing the prevalence, 
characteristics and management of CTO in patients undergoing CCTA for suspected 
coronary artery disease (CAD) have not been reported.
What might this study add?
The present study demonstrates that: (1) CTO are not uncommon in a contemporary 
CCTA population, and are more prevalent in individuals with obstructive CAD; (2) the 
presence of CTO is strongly associated with age, gender, angina status and CAD risk 
factors and (3) despite the presence of symptoms, the majority of patients with CCTA-
identified CTO were managed medically, with CTO being a stronger predictor of surgical 
rather than percutaneous revascularisation.
How might this impact on clinical practice?
This study offers information incremental to developing a future predictive model for 
identifying the presence of CTO in patients undergoing non-invasive CCTA, and 
indicates the need for defining the most optimal treatment strategies of CTO in a 
contemporary CCTA population.
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Figure 1. 
Early referral patterns (within 90 days after CT angiography) of patients with severe CAD 
(≥70%) with and without CTO (n=1372). Values are n (%). *p=0.02. †p<0.001. CABG, 
coronary artery bypass grafting; CAD, coronary artery disease; CCTA, coronary CT 
angiography; CTO, chronic total occlusion; NS, non-significant; PCI, percutaneous coronary 
intervention.
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Table 1
Baseline characteristics of the study population (n=23 745)
Chronic total occlusion
p ValueNo (n=23 403) Yes (n=342)
Age, years 57.2±12.6 64.7±10.8 <0.0001
Male 12 671 (54.1) 255 (74.6) <0.001
Hypertension 11 385 (49.1) 227 (67.2) <0.001
Hyperlipidaemia 12 566 (54.1) 226 (66.9) <0.001
Diabetes 3359 (14.4) 80 (23.7) <0.001
Family history of premature CAD 8476 (36.8) 124 (36.9) 0.96
Current smoker 4144 (17.8) 94 (27.8) <0.001
BMI, kg/m2* 27.3±5.2 27.7±4.6 0.04
LVEF, %† 61.8±11.4 57.2±15.4 0.0009
 Normal LVEF, >50% 6551 (85.3) 124 (70.5) <0.001
 Moderate LVEF, >30% ≤50% 968 (12.6) 38 (21.6) <0.001
 Low LVEF, ≤30% 161 (2.1) 14 (8.0) <0.001
Pretest probability of obstructive CAD 34.6±29.1 41.9±33.5 <0.0001
 Low 8970 (43.7) 141 (42.6) 0.68
 Intermediate 9520 (46.4) 121 (36.6) <0.001
 High 2021 (9.9) 69 (20.9) <0.001
Chest pain
 Asymptomatic 6886 (33.6) 135 (40.8) 0.006
 Non-cardiac 2333 (11.4) 38 (11.5) 0.95
 Atypical angina 8235 (40.2) 84 (25.4) <0.001
 Typical angina 3057 (14.9) 74 (22.4) <0.001
CCTA results (no. of vessels with ≥50% stenosis, including CTO)
 Normal 10 097 (43.1) 0 <0.001
 Non-obstructive 8089 (34.6) 0 <0.001
 One-vessel disease 2984 (12.8) 113 (33.0) <0.001
 Two-vessel disease 1228 (5.3) 109 (31.9) <0.001
 Three-vessel disease or left main 1005 (4.3) 120 (35.1) <0.001
Values are mean±SD or n (%).
*
BMI available in 78% of the cohort.
†
LVEF available in 33% of the cohort.
BMI, body mass index; CAD, coronary artery disease; CCTA, coronary CT angiography; CTO, chronic total occlusion; LVEF, left ventricular 
ejection fraction.
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Table 2
Location and plaque morphology of chronic total occlusion
No. of occluded segments (%)
Plaque composition (%)
Calcified Partially calcified Non-calcified
Left main 0
LAD
 Proximal 29 (8.5) 25.2±30.8 54.8±33.0* 20.0±24.3†
 Medial 50 (14.6) 29.3±36.8 47.7±35.5* 22.9±30.8†
 Distal 26 (7.6) 13.4±19.5‡ 49.5±28.5* 37.1±31.8
 Diagonal artery 1 29 (8.5) 32.5±38.5 49.6±37.6 17.9±26.4†
 Diagonal artery 2 10 (2.9) 21.7±24.3 54.2±29.9* 24.1±38.2
LCX
 Proximal 17 (5.0) 13.5±18.4 55.4±33.7* 31.1±35.3
 Distal 47 (13.7) 26.9±28.5 52.6±33.8* 20.5±28.6†
 Obtuse marginal 1 33 (9.7) 24.5±32.5 56.3±33.2* 19.2±25.0†
 Obtuse marginal 2 13 (3.8) 17.5±16.9 62.2±25.5* 20.3±21.7†
 Left posterolateral artery 0
RCA
 Proximal 61 (17.8) 24.1±26.8 52.6±29.5* 23.3±27.2†
 Medial 111 (32.5) 26.3±28.9 54.0±30.6* 19.7±25.7†
 Distal 63 (18.4) 23.0±27.2 58.8±32.1* 18.1±25.4†
 Right posterolateral artery 13 (3.8) 44.9±35.7‡ 46.2±35.8 8.9±20.0†
 Posterior descending artery 25 (7.3) 41.2±38.3‡ 46.6±40.1 12.2±26.0†
Values are mean±SD or n (%).
*Significant differences between CP versus PCP.
†Significant differences between PCP versus NCP.
‡Significant differences between CP versus NCP.
CP, calcified plaque; LAD, left anterior descending artery; LCX, left circumflex artery; NCP, non-calcified plaque; PCP, partially calcified plaque; 
RCA, right coronary artery.
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Table 4
Early referral patterns of patients with severe CAD (≥70%) with and without CTO stratified by the presence of 
coronary vessel disease on CCTA (n=1372)
Chronic total occlusion
No (n=1091) Yes (n=281) p Value
Early medical therapy
 One-vessel disease 323 (64.0) 68 (78.2) 0.01
 Two-vessel disease 207 (62.4) 56 (62.2) 0.98
 Three-vessel disease or left main 136 (53.5) 47 (45.2) 0.15
Early PCI
 One-vessel disease 167 (33.1) 18 (20.7) 0.02
 Two-vessel disease 101 (30.4) 24 (26.7) 0.49
 Three-vessel disease or left main 73 (28.7) 26 (25.0) 0.47
Early CABG
 One-vessel disease 15 (3.0) 1 (1.2) 0.49
 Two-vessel disease 24 (7.2) 10 (11.1) 0.23
 Three-vessel disease or left main 45 (17.7) 31 (29.8) 0.01
CABG, coronary artery bypass grafting; CAD, coronary artery disease; CCTA, coronary CT angiography; CTO, chronic total occlusion; PCI, 
percutaneous coronary intervention.
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Table 5
Clinical presentation of patients with CTO referred to PCI versus CABG for early coronary revascularisation 
(n=110)
Early PCI (n=68) Early CABG (n=42) p Value
Age, years 63.8±10.9 65.2±8.7 0.55
Male 46 (67.7) 33 (78.6) 0.22
Hypertension 44 (65.7) 21 (51.2) 0.14
Hyperlipidaemia 42 (63.6) 35 (85.4) 0.02
Diabetes 15 (22.1) 10 (24.4) 0.78
Family history of premature CAD 24 (36.4) 14 (34.2) 0.82
Current smoker 20 (29.4) 10 (24.4) 0.57
BMI, kg/m2 27.7±3.9 27.6±3.9 0.69
LVEF, %* 59.4±12.1 52.2±14.1 0.03
Pretest probability of obstructive CAD 48.5±33.5 53.4±33.3 0.37
 Low 21 (31.3) 10 (26.3) 0.59
 Intermediate 29 (43.3) 16 (42.1) 0.91
 High 17 (25.4) 12 (31.6) 0.49
Chest pain
 Asymptomatic 18 (26.9) 10 (26.3) 0.95
 Non-cardiac 7 (10.5) 5 (13.2) 0.75
 Atypical angina 25 (37.3) 10 (26.3) 0.25
 Typical angina 17 (25.4) 13 (34.2) 0.34
CCTA results (no. of vessels with ≥50% stenosis, including CTO)
 One-vessel disease 18 (26.5) 1 (2.4) 0.001
 Two-vessel disease 24 (35.3) 10 (23.8) 0.21
 Three-vessel disease or left main 26 (38.2) 31 (73.8) <0.001
*
LVEF available only in 42% of the CTO group.
BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CCTA, coronary CT angiography; CTO, chronic 
total occlusion; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention.
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